Abstract
Thyroid FNAs are amongst the most commonly encountered cytology samples. Thus, cytologic classification systems are well established in this area. Three major classification systems are presented at a glance, with a brief summary of the most recent Bethesda System updates. This chapter provides an introduction to what cytology can and can’t do in the thyroid gland and lays out a guide to the main morphological patterns seen in thyroid FNAs, moving systematically from cytoarchitectural features to cytomorphology and background elements.
In a dedicated section, specific challenging areas are highlighted, including cystic and lymphoid-rich lesions, amongst others. Diagnostic pitfalls are also discussed, with the inclusion of tips to avoid errors in interpretation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kolata G. It’s not cancer: doctors reclassify a thyroid tumor. The New York Times [Internet]. 2016. [cited 2017 Mar 3]. https://www.nytimes.com/2016/04/15/health/thyroid-tumor-cancer-reclassification.html.
Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LDR, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016;2(8):1023–9.
Guidelines of the Papanicolaou Society of Cytopathology for the examination of fine-needle aspiration specimens from thyroid nodules. The Papanicolaou Society of Cytopathology Task Force on standards of practice. Diagn Cytopathol. 1996;15(1):84–9.
Royal College of Pathologists (United Kingdom). Guidance on the reporting of thyroid cytology specimens [Internet]. http://ukeps.com/docs/thyroidfna.pdf.
RCPA. Cancer protocols [Internet]. [cited 2017 Mar 8]. http://www.rcpa.edu.au/Library/Practising-Pathology/Structured-Pathology-Reporting-of-Cancer/Cancer-Protocols.
Ali SZ, Cibas ES. The Bethesda system for reporting thyroid cytopathology II. Acta Cytol. 2016;60(5):397–8.
Ali SZ, Cibas E, editors. The Bethesda system for reporting thyroid cytopathology: definitions, criteria, and explanatory notes [Internet]. 2nd ed. Berlin: Springer International Publishing; 2018. [cited 2018 Jun 18]. //www.springer.com/gp/book/9783319605692.
Cibas ES, Ali SZ, NCI Thyroid FNA State of the Science Conference. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2009;132(5):658–65.
Pusztaszeri M, Rossi ED, Auger M, Baloch Z, Bishop J, Bongiovanni M, et al. The Bethesda system for reporting thyroid cytopathology: proposed modifications and updates for the second edition from an international panel. Acta Cytol. 2016;60(5):399–405.
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
Gan TRX, Nga ME, Lum JHY, Wong WM, Tan WB, Parameswaran R, et al. Thyroid cytology-nuclear versus architectural atypia within the “Atypia of undetermined significance/follicular lesion of undetermined significance” Bethesda category have significantly different rates of malignancy: subclassifying “atypical” thyroid FNACs. Cancer Cytopathol. 2017;125(4):245–56.
Ho AS, Sarti EE, Jain KS, Wang H, Nixon IJ, Shaha AR, et al. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid. 2014;24(5):832–9.
Straccia P, Rossi ED, Bizzarro T, Brunelli C, Cianfrini F, Damiani D, et al. A meta-analytic review of the Bethesda system for reporting thyroid cytopathology: has the rate of malignancy in indeterminate lesions been underestimated? Cancer Cytopathol. 2015;123(12):713–22.
Önder S, Firat P, Ates D. The Bethesda system for reporting thyroid cytopathology: an institutional experience of the outcome of indeterminate categories. Cytopathology. 2014;25(3):177–84.
Bychkov A, Keelawat S, Agarwal S, Jain D, Jung CK, Hong S, et al. Impact of non-invasive follicular thyroid neoplasm with papillary-like nuclear features on the Bethesda system for reporting thyroid cytopathology: a multi-institutional study in five Asian countries. Pathology (Phila). 2018;50(4):411–7.
Alexander EK, Kennedy GC, Baloch ZW, Cibas ES, Chudova D, Diggans J, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012;367(8):705–15.
Harvey AM, Truong LD, Mody DR. Diagnostic pitfalls of Hashimoto’s/lymphocytic thyroiditis on fine-needle aspirations and strategies to avoid overdiagnosis. Acta Cytol. 2012;56(4):352–60.
Demay RM. The art & science of cytopathology. 2nd ed. Chicago: American Society for Clinical Pathology; 2011. 2076p.
Sidawy MK, Costa M. The significance of paravacuolar granules of the thyroid. A histologic, cytologic and ultrastructural study. Acta Cytol. 1989;33(6):929–33.
Geddie WR, Bedard YC, Strawbridge HT. Medullary carcinoma of the thyroid in fine-needle aspiration biopsies. Am J Clin Pathol. 1984;82(5):552–8.
Kini SR, Miller JM, Hamburger JI, Smith MJ. Cytopathologic features of medullary carcinoma of the thyroid. Arch Pathol Lab Med. 1984;108(2):156–9.
Dahlgren M, Khosroshahi A, Nielsen GP, Deshpande V, Stone JH. Riedel’s thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res. 2010;62(9):1312–8.
Falhammar H, Juhlin CC, Barner C, Catrina S-B, Karefylakis C, Calissendorff J. Riedel’s thyroiditis: clinical presentation, treatment and outcomes. Endocrine. 2018;60(1):185–92.
Nixon IJ, Coca-Pelaz A, Kaleva AI, Triantafyllou A, Angelos P, Owen RP, et al. Metastasis to the thyroid gland: a critical review. Ann Surg Oncol. 2017;24(6):1533–9.
Deeken-Draisey A, Yang G-Y, Gao J, Alexiev BA. Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study. Hum Pathol. 2018;82:140–8.
Ng W-K, Ip P, Choy C, Collins RJ. Cytologic and immunocytochemical findings of anaplastic large cell lymphoma: analysis of ten fine-needle aspiration specimens over a 9-year period. Cancer. 2003;99(1):33–43.
Pusztaszeri MP, Krane JF, Faquin WC. BRAF testing and thyroid FNA. Cancer Cytopathol. 2015;123(12):689–95.
Leslie C, Grieu-Iacopetta F, Richter A, Platten M, Murray J, Frost FA, et al. BRAF p.Val600Glu (V600E) mutation detection in thyroid fine needle aspiration cell block samples: a feasibility study. Pathology (Phila). 2015;47(5):432–8.
Wobker SE, Kim LT, Hackman TG, Dodd LG. Use of BRAF v600e immunocytochemistry on FNA direct smears of papillary thyroid carcinoma: BRAF immunocytochemistry for FNA smears. Cancer Cytopathol. 2015;123(9):531–9.
Trimboli P, Treglia G, Condorelli E, Romanelli F, Crescenzi A, Bongiovanni M, et al. BRAF-mutated carcinomas among thyroid nodules with prior indeterminate FNA report: a systematic review and meta-analysis. Clin Endocrinol. 2016;84(3):315–20.
Hirokawa M, Carney JA. Cell membrane and cytoplasmic staining for MIB-1 in hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol. 2000;24(4):575–8.
García-Pascual L, Barahona M-J, Balsells M, del Pozo C, Anglada-Barceló J, Casalots-Casado J, et al. Complex thyroid nodules with nondiagnostic fine needle aspiration cytology: histopathologic outcomes and comparison of the cytologic variants (cystic vs. acellular). Endocrine. 2011;39(1):33–40.
Verma D, Puri V, Agarwal S, Bhaskar A. Primary thyroid lymphoma: a rare disease. J Cytol. 2014;31(4):218–20.
Sharma A, Jasim S, Reading CC, Ristow KM, Villasboas Bisneto JC, Habermann TM, et al. Clinical presentation and diagnostic challenges of thyroid lymphoma: a cohort study. Thyroid. 2016;26(8):1061–7.
Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol. 2007;31(8):1256–64.
Kane SV, Sharma TP. Cytologic diagnostic approach to poorly differentiated thyroid carcinoma: a single-institution study. Cancer Cytopathol. 2015;123(2):82–91.
Saglietti C, Onenerk AM, Faquin WC, Sykiotis GP, Ziadi S, Bongiovanni M. FNA diagnosis of poorly differentiated thyroid carcinoma. A review of the recent literature. Cytopathology. 2017;28(6):467–74.
Bongiovanni M, Bloom L, Krane JF, Baloch ZW, Powers CN, Hintermann S, et al. Cytomorphologic features of poorly differentiated thyroid carcinoma: a multi-institutional analysis of 40 cases. Cancer. 2009;117(3):185–94.
Haberal AN, Toru S, Ozen O, Arat Z, Bilezikçi B. Diagnostic pitfalls in the evaluation of fine needle aspiration cytology of the thyroid: correlation with histopathology in 260 cases. Cytopathology. 2009;20(2):103–8.
Silva de Morais N, Stuart J, Guan H, Wang Z, Cibas ES, Frates MC, et al. The impact of Hashimoto thyroiditis on thyroid nodule cytology and risk of thyroid cancer. Endocr Soc. 2019;3(4):791–800.
Wei S, Baloch ZW, LiVolsi VA. Thyroid carcinoma in patients with graves’ disease: an institutional experience. Endocr Pathol. 2015;26(1):48–53.
Mai KT, Landry DC, Thomas J, Burns BF, Commons AS, Yazdi HM, et al. Follicular adenoma with papillary architecture: a lesion mimicking papillary thyroid carcinoma. Histopathology. 2001;39(1):25–32.
Pusztaszeri MP, Krane JF, Cibas ES, Daniels G, Faquin WC. FNAB of benign thyroid nodules with papillary hyperplasia: a cytological and histological evaluation. Cancer Cytopathol. 2014;122(9):666–77.
Agarwal C, Kaushal M. Parathyroid lesions: difficult diagnosis on cytology. Diagn Cytopathol. 2016;44(8):704–9.
Bondeson L, Bondeson AG, Nissborg A, Thompson NW. Cytopathological variables in parathyroid lesions: a study based on 1,600 cases of hyperparathyroidism. Diagn Cytopathol. 1997;16(6):476–82.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Nga, M.E. (2021). Approach to Thyroid Cytology. In: Practical Diagnostic Approaches in Non-Gynaecologic Cytology. Springer, Singapore. https://doi.org/10.1007/978-981-15-2961-0_5
Download citation
DOI: https://doi.org/10.1007/978-981-15-2961-0_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-2960-3
Online ISBN: 978-981-15-2961-0
eBook Packages: MedicineMedicine (R0)